News & Updates
Showing Endocrinology articles
Showing
Show Multimedia Only

Semaglutide may extend benefits in COVID-19
14 Aug 2026
byAudrey Abella
In a prespecified secondary analysis of the phase III FLOW trial, semaglutide reduces the risk of serious infections and COVID-19 events in individuals with type 2 diabetes (T2D) and chronic kidney disease (CKD).
Semaglutide may extend benefits in COVID-19
14 Aug 2026
Bariatric surgery in teens with obesity reduces BMI, cardiometabolic risk factors
06 Aug 2026
byStephen Padilla
Adolescents with obesity who underwent bariatric surgery (BS) show substantial and sustained improvements in BMI and cardiometabolic health, according to a study.







